Connexion
E-mail
Mot de passe
Afficher le mot de passe
Retenir
Mot de passe oublié ?
Devenir membre gratuitement
Inscription
Inscription
Devenir membre
Inscription gratuite
Devenir client
Découvrez nos services
Paramètres
Paramètres
Cotations dynamiques 
OFFON

ROCHE HOLDING AG

(RO)
  Rapport
SynthèseCotationsGraphiquesActualitésNotationsAgendaSociétéFinancesConsensusRévisionsDérivésFondsCommunauté 
SynthèseToute l'actualitéReco analystesAutres languesCommuniquésPublications officiellesActualités du secteur
Actualités dans d'autres langues sur ROCHE HOLDING AG
09:55OPINIONES DE LOS ANALISTAS DEL DÍA : Endesa, Flatexdegiro, Netflix, Kering, Lonza, Philips..
09:52MÄRKTE EUROPA/Wenig verändert - Flut von Unternehmenszahlen
09:40Donde todo es cuestión de resultados empresariales, bitcoin y metavers
09:11ROCHE : Nine-month 2021 Investor update
08:13ROCHE : Pharmakonzern Roche legt die Messlatte etwas höher
08:04MÄRKTE EUROPA/Wenig verändert erwartet - Zahlen und Inflation im Blick
07:47Roche lässt mit erhöhter Jahresprognose Coronakrise hinter sich
07:41Roche hebt wegen anhaltend starker Diagnostik Prognose an
07:35ROCHE : Q3 Sales Jump 8% on New Medicines Growth; FY Sales Guidance Raised
07:33ROCHE : lifts 2021 outlook as Delta variant spurs COVID-19 test demand
07:32Pharmakonzern Roche hebt Umsatzziel an - Corona-Geschäfte laufen gut
07:13ROCHE : raises 2021 outlook as COVID-19 tests continue powering sales
07:11ROCHE : mit starkem Wachstum in den ersten neun Monaten 2021 – Ausblick für das Gesa..
07:11ROCHE : reports strong growth in the first nine months – outlook for 2021 raised - I..
07:11ROCHE : Nine-month 2021 Presentation without appendix
07:11ROCHE : Nine-month 2021 Presentation with appendix
07:08Roche hebt dank gutem Wachstum Jahresprognose leicht an
07:01ROCHE : reports strong growth in the first nine months – outlook for 2021 raised
05:36Roche 3Q Sales Grew; Raises Outlook
19/10ADRs End Higher; Ericsson, Danone Among Companies Actively Trading
19/10Wall Street rises as investors bet on positive earnings season
19/10Health Care Up Sharply After Strong J&J Earnings -- Health Care Roundup
19/10ATEA PHARMACEUTICALS : Shares Plunge After COVID-19 Pill Candidate Misses Phase 2 Primary ..
19/10Aktien Schweiz knapp behauptet - Nestle und Roche belasten SMI
19/10Atea plunges after COVID-19 treatment fails to help patients in study
19/10Atea se desploma tras un estudio que no muestra eficacia en su tratamiento del COVID
19/10ROCHE : Atea Pharmaceuticals COVID-19 Drug Fails To Meet Phase Two Endpoint
19/10AUSBLICK ROCHE : Umsatz von 46,5 Mrd Franken nach 9 Monaten erwartet
19/10Roche-Partner Atea erreicht Ziele in Studie mit Corona-Pille nicht
19/10Atea Shares Fall 75% After Covid-19 Trial Misses Objective
19/10Atea's Covid-19 Trial Misses Objective in Overall Patient Population
19/10European stocks rise as defensive buying helps offset losses on downbeat earnings
18/10GLOBAL MARKETS LIVE : Valneva, Glencore, Facebook, Roche, Hertz...
18/10Today on Wall Street: This is the real test
18/10BOURSE DE MADRID : La feria de resultados vuelve a estar en pleno apogeo
18/10Roche baut technologische Innovation in Pathologie mit Ibex-Zusammenarbeit aus
18/10Roche Announces Collaboration with Ibex Medical Analytics to Develop Artificial Intelli..
18/10ROCHE : Heirs to Shut Down Philanthropic Foundation Focused on Nature Conservation
18/10ROCHE : Wins US FDA Nod For Non-Small Cell Lung Cancer Therapy Tecentriq
17/10ROCHE : family shareholders will maintain stability - vice chairman
15/10ROCHE : FDA Approves Genentech's Tecentriq as Adjuvant Treatment for Certain People With E..
15/10ROCHE : US FDA approves Roche's Tecentriq as adjuvant treatment for certain people with ea..
15/10PRESS RELEASE : US FDA approves Roche's Tecentriq -2-
15/10PRESS RELEASE : US FDA approves Roche's Tecentriq as adjuvant treatment for certain people..
15/10ROCHE : FDA erteilt Zulassung für Tecentriq bei nicht-kleinzelligem Lungenkrebs
15/10Aktien Schweiz gehen mit Aufschlägen ins Wochenende
15/10GENENTECH : FDA Approves Tecentriq as Adjuvant Treatment for Certain Lung Cancer Patients
15/10ROCHE : Joins PathAI to Develop AI-Based Image Analysis Workflow for Pathologists
15/10Roche erhält Zulassung von Swissmedic für Krebsmittel Gavreto
15/10Roche kündigt Zusammenarbeit mit PathAI im Bereich künstliche Intelligenz an
15/10ROCHE : announces PathAI collaboration for artificial intelligence-based digital pathology..
15/10PRESS RELEASE : Roche announces PathAI collaboration for artificial intelligence-based dig..
15/10Roche Announces PathAI Collaboration for Artificial Intelligence-Based Digital Patholog..
14/10ROCHE : U.S. FDA advisers to review Merck's oral COVID-19 drug next month
14/10Aktien Schweiz gehen mit Aufschlägen aus dem Handel
14/10Roche-Partner Regeneron erhält von FDA vorrangige Prüfung von REGEN-COV
14/10ROCHE : FDA accepts REGEN-COV (casirivimab and imdevimab) for priority review for treatmen..
14/10ROCHE : Scores Wins In Blood Cancer, Rare Nervous Disorder Therapeutic Areas
14/10ROCHE : Invitation to Roche's Virtual Event "Digitalization along the value chain"
14/10ROCHE : Rare Central Nervous System Disease Therapy Reduces Relapses In Patients
14/10Roche erhält EU-Zulassung für schnelle Gazyvaro-Infusion - Neue Enspryng-Daten
14/10ROCHE : Wins EU Nod For Shorter Gazyvaro Infusion Time in Follicular Lymphoma Patients
14/10ROCHE : Gazyvaro shorter 90-minute infusion time approved in Europe for people with previo..
14/10ROCHE : New four-year data show Roche's ENSPRYNG significantly reduces debilitating relaps..
14/10PRESS RELEASE : New four-year data show Roche's -2-
14/10PRESS RELEASE : New four-year data show Roche's ENSPRYNG significantly reduces debilitatin..
14/10Roche Holding Ag Announces New Longer-Term Efficacy and Safety Data for ENSPRYNG
14/10ROCHE : New 4-Year Data Show Genentech's Enspryng (satralizumab-mwge) Significantly Reduce..
14/10ROCHE : Gazyvaro shorter 90-minute infusion time approved in Europe for people with previo..
14/10PRESS RELEASE : Roche's Gazyvaro shorter 90-minute -2-
14/10PRESS RELEASE : Roche's Gazyvaro shorter 90-minute infusion time approved in Europe for pe..
14/10Roche’s Gazyvaro Shorter 90-Minute Infusion Time Gets Approval in Europe for People wit..
13/10Aktien Schweiz mit leichtem Plus zur Wochenmitte
13/10SYNAIRGEN : Appoints Chugai Pharma Executive as Chief Regulatory Officer
13/10REMINDER : Invitation to Roche's 3rd Quarter Sales 2021 Webinar
1  2  3  4  5  6  7  8  9  10Suiv.
Prochain événement sur ROCHE HOLDING AG